De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegeneration and the microbiome using C. elegans.
ServicesAgeingMicrobiome Neurodegeneration ToxicityTransgenics
Who we helpBiotechHealth Products & ManufacturingPharmaAcademia
CompanyAbout UsOur TeamTestimonialsJobs
Why C. elegans?TechnologyNewsResourcesContact
LegalPrivacyCookies